Next |
home / stock / xsnx / xsnx message board
Subject | By | Source | When |
---|---|---|---|
Looks good today on low vol, watching | InvestorNews1 | investorshub | 02/15/2023 8:25:32 PM |
Unfortunately... | splintered sunlight | investorshub | 01/26/2023 4:52:23 PM |
Looks like $XSNX is owning up to owing | BooDog | investorshub | 01/26/2023 4:09:49 PM |
What do you make of this? | splintered sunlight | investorshub | 01/24/2023 2:17:48 PM |
8K yesterday..... | splintered sunlight | investorshub | 01/24/2023 1:53:03 PM |
Something smells fishy here.... | splintered sunlight | investorshub | 01/12/2023 7:16:44 PM |
Thanks - I will get familiar with $XSNX | splintered sunlight | investorshub | 01/06/2023 3:54:31 PM |
They've got things happening, just not getting their | BooDog | investorshub | 01/06/2023 3:28:16 PM |
Going to read the board over the weekend. | splintered sunlight | investorshub | 01/06/2023 3:12:22 PM |
NovAccess Global Receives FDA Approval of Orphan Drug | BooDog | investorshub | 10/26/2022 2:54:18 PM |
NovAccess Global Announces Fireside Chat with Board Member Perspectives | BooDog | investorshub | 10/25/2022 5:49:12 PM |
Read the 8K and understand the dilution this | BooDog | investorshub | 10/05/2022 9:39:14 PM |
Welcome to what dark side? | cashmagnet | investorshub | 10/05/2022 9:30:32 PM |
I'm a small-fry investor with a minor stake | cashmagnet | investorshub | 10/05/2022 9:25:02 PM |
Thinking .01 until they file their IND. | BooDog | investorshub | 09/30/2022 2:11:23 PM |
Whelp, welcome to the dark side. | BooDog | investorshub | 09/30/2022 11:04:10 AM |
https://novaccessglobal.com/news/ Some good stuff in there. And | BooDog | investorshub | 09/28/2022 5:58:42 PM |
With that news, it's a shame this isn't | TRADER99 | investorshub | 07/19/2022 7:01:05 PM |
whytestocks: $XSNX News Article - CORRECTION: NovAccess Global Announces Filing of Orphan Drug Appli | whytestocks | investorshangout | 07/19/2022 4:55:54 PM |
whytestocks: $XSNX News Article - NovAccess Global Announces Filing of Orphan Drug Application for T | whytestocks | investorshangout | 07/19/2022 4:52:14 PM |
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / May 21, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a pioneering biomedical company developing innovative immunotherapies for brain tumor patients, today announced it has submitted a provisional patent for new intellectual property developed at Cedars-Sinai to advance...
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company ...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...